Hsiao D. Lieu - 05 Oct 2021 Form 4 Insider Report for NGM BIOPHARMACEUTICALS INC

Role: SVP, Chief Medical Officer
Signature: /s/ Hsiao D. Lieu
Issuer symbol: N/A
Transactions as of: 05 Oct 2021
Net transactions value: -$19,880
Form type: 4
Filing time: 07 Oct 2021, 20:04:44 UTC
Previous filing: 13 Aug 2021
Next filing: 04 Mar 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NGM	Common Stock	Options Exercise	$24,120	+2,000		$12.06^*	2,000	05 Oct 2021	Direct	F1
transaction	NGM	Common Stock	Sale	$44,000	-2,000	-100%	$22.00^*	0	05 Oct 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NGM	Stock Option (Right to Buy)	Options Exercise	$0	-2,000	-1%	$0.000000	190,000	05 Oct 2021	Common Stock	2,000	$12.06	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 24, 2021.
F2	The shares subject to the stock option vest over a four-year period measured from the grant date, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.